UF & Shands Hospital
Gainesville, Florida, 32611, United States
NCT Number: NCT01965769
Omitting evaluation of gastric residual contents prior to feeding very premature infants will increase the feeding intake at 2 weeks, and total caloric intake and growth by 3 weeks, as well as decrease the time required for parenteral nutrition.
Looking for future studies?
Notify MeUp to 3 day
All sexes
Interventional
Not applicable
Gainesville, Florida, 32611, United States
Infants were randomized into 2 groups. Group 1 had no gastric residuals evaluated prior to feeding. Group 2 had gastric residuals evaluated prior to feeding. Nutritional outcomes were compared between groups.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Infants will not receive routine gastric residual evaluation prior to feeding.
Time frame: Baseline to 2 weeks
Time frame: Baseline to approximately 21 days
Time frame: Baseline to approximately 21 days
Time frame: Baseline to approximately 90 days
Time frame: Baseline to 42 days
Direct bilirubin
Time frame: Baseline to approximately 90 days
Weight, length and head circumference
Time frame: Baseline to approximately 90 days
Time frame: Baseline to approximately 90 days
Time frame: Baseline to approximately 21 days
University of Florida
Other
Effects Of Not Measuring Gastric Residuals Prior To Enteral Bolus Feeding On Gastrointestinal Function And Feeding Tolerance In Very Low Birth Weight Infants
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03114644
Female Urogenital Diseases and Pregnancy Complications, Mother-Baby Synchrony
Amiens, Picardie, France
View Trial DetailsNCT03093337
Cognition Disorders, Cognitive Dysfunction
Albi, Midi-Pyrénées, France
View Trial DetailsNCT02184650
Delayed Mental Development, Female Urogenital Diseases and Pregnancy Complications
Paris, France
View Trial DetailsNCT06959290
Agnosia, Female Urogenital Diseases and Pregnancy Complications
Istanbul, Turkey (Türkiye)
View Trial Details